Install
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Accumulate Fortis Healthcare; target of Rs 2320: Prabhudas Lilladher
4+ hour, 35+ min ago (209+ words) TradingView Accumulate Fortis Healthcare; target of Rs 2320: Prabhudas Lilladher Prabhudas Lilladher's research report on Fortis Healthcare We attended HUL's analyst meet, where management expressed confidence in achieving volume-led revenue growth. HUL new strategy indicates shift from WIMI ( winning in many…...
Caring Brands completes initial $4.6M closing of $9M private placement to fund sales, marketing
4+ day, 20+ hour ago (112+ words) TradingView Caring Brands completes initial $4.6M closing of $9M private placement to fund sales, marketing Caring Brands completed an initial $4.6 million closing of a $9.0 million private placement to fund salesforce and marketing launches. - Completed initial closing of $4.6M in convertible preferred shares under…...
World No.1 with 56% Profit Surge: Saint Bella Redefines Family Care Economics
5+ day, 9+ hour ago (669+ words) HONG KONG, Sept 2, 2026 - (ACN Newswire) - Postpartum care has historically presented a challenging unit economic profile: low purchase frequency, high labor intensity, and significant execution friction across regions. Constrained by these structural headwinds, most industry operators operate near break-even levels. Saint…...
CVS vs. UNH: Which Health Insurance Stock Has More Upside Now?
6+ day, 20+ hour ago (447+ words) Over the past six months, CVS and UNH shares have risen 13.9% and 33.2%, respectively, both outperforming the S&P 500 composite’s 11.9% growth. Let’s take a closer look at which stock has the stronger investment case today. The Case for CVS CVS Health…...
Kennedy advisers recommend doubling US autism spending on care, family support
1+ week, 3+ day ago (23+ words) TradingView Kennedy advisers recommend doubling US autism spending on care, family support...
Here's Why Investors Should Retain Humana Stock for Now
1+ week, 4+ day ago (317+ words) Humana Inc. HUM benefits from a strong care delivery model centered on value-based care, increasing premiums, strategic acquisitions, an aging population in the United States and solid cash generation capacity. HUM’s shares have surged 55.7% in the year-to-date period compared with…...
USPH: Exclusive hospital alliances and strong partner model drive growth and margin expansion
1+ week, 4+ day ago (75+ words) TradingView USPH: Exclusive hospital alliances and strong partner model drive growth and margin expansion A partnership-driven model supports national expansion via organic growth and acquisitions, maintaining local brands and partner retention. New hospital alliances, especially with NYU Langone, are expected…...
REP: Healthcare pivot accelerates as retail assets are sold, lowering gearing and boosting flexibility
1+ week, 5+ day ago (74+ words) TradingView REP: Healthcare pivot accelerates as retail assets are sold, lowering gearing and boosting flexibility A strategic pivot to healthcare is underway, with five retail assets sold for $218.6m and gearing set to drop to 16.8%. FY26 FFO fell to $14.7m, but recurring property…...
UnitedHealth vs. Elevance: Which Managed-Care Stock Is a Better Buy?
1+ week, 5+ day ago (426+ words) UnitedHealth combines its insurance operations with a broad health-services platform, while Elevance is leveraging its insurance business alongside Carelon to expand its healthcare services capabilities. Their differing business mixes and approaches to Medicare Advantage and care management provide a useful…...
Humanwell Healthcare: Net profit rose 15.15% year-over-year on stable revenue and improved operational efficiency
1+ week, 6+ day ago (70+ words) TradingView Humanwell Healthcare: Net profit rose 15.15% year-over-year on stable revenue and improved operational efficiency Revenue remained stable at RMB 12.06 billion, while net profit attributable to shareholders rose 15.15% year-over-year to RMB 1.33 billion. The company strengthened its core pharmaceutical segments, advanced internationalization,…...